Tag: Breast

Search News
Categories
Archives
2019 ASCO Annual Meeting

4th June 2019

Professor Peter Schmid, Lead of the Centre for Experimental Cancer Medicine at the Barts Cancer Institute, Queen Mary University of London, attended this year’s ASCO Annual Meeting and today presented updated survival data from the IMpassion130 trial.

Read more

NHS Innovation Accelerator

5th March 2019

Dr Ranjit Manchanda from Barts Cancer Institute, Queen Mary University of London, and Consultant Gynaecological Oncologist at Barts Health NHS Trust, was announced today as one of 13 Fellows to join the NHS Innovation Accelerator (NIA), which supports dedicated individuals to scale their high impact, evidence-based innovations across the NHS and wider healthcare system. Dr Manchanda’s innovation is a […]

Read more

‘The neighbouring effect’: Centrosomal abnormalities drive invasion of surrounding cells

19th November 2018

Centrosomal amplification, a particular change that occurs within some cancer cells, has been shown to drive the invasion of neighbouring cancer cells.

Read more

New phase III clinical trial using combination therapy extends survival in triple-negative breast cancer

22nd October 2018

Research provides new hope for people with an aggressive type of breast cancer.

Read more

Immunotherapy shows promise for patients with metastatic triple-negative breast cancer

17th October 2018

Immunotherapy has been shown to confer an encouraging survival benefit in patients with metastatic triple-negative breast cancer (mTNBC).

Read more

Research suggests improved detection rates are needed to maximise cancer prevention

8th June 2018

Current detection strategies are found to have identified only 2.6% of the BRCA gene mutation carriers in the Greater London population, according to a recent study published in the Journal of Medical genetics. The findings of the study, performed by researchers from the BCI’s Centre for Experimental Cancer Medicine, led by Dr Ranjit Manchanda, suggest that enhanced and new approaches are required to maximise the opportunity for breast and ovarian cancer prevention.

Read more

Search News
Categories
Archives